[Federal Register Volume 87, Number 90 (Tuesday, May 10, 2022)]
[Notices]
[Pages 28012-28013]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-09949]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Council for the 
Elimination of Tuberculosis (ACET). This meeting is open to the public 
and limited to 1,000 audio and web conference lines. Members of the 
public are welcome to listen to the meeting by accessing the telephone 
number and web access provided in the addresses section below. Time 
will be available for public comment (registration required to provide 
oral comment).

DATES: The meeting will be held on June 21, 2022, from 10:00 a.m. to 
4:30 p.m., EDT, and June 22, 2022, from 10:00 a.m. to 12:05 p.m., EDT. 
Written comments must be received on or before June 7, 2022. 
Registration to make oral comments must be submitted by June 16, 2022.

ADDRESSES: The telephone access number is 1-669-254-5252, Webinar ID: 
160 137 0413, and the Passcode is 37403108. The web conference access 
is https://cdc.zoomgov.com/j/1601370413?pwd=T0pucU1yNENQVUlRNUNVUVBKbHh2UT09, and the Passcode is 
[caret]Sm35?s2. The number of available audio and web conference lines 
is 1,000.

FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management 
Lead, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, 
CDC, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, GA 30329-4027, 
Telephone:(404)639-3423; Email: <a href="/cdn-cgi/l/email-protection#78161b10100b0c08081714111b01381b1c1b561f170e"><span class="__cf_email__" data-cfemail="b4dad7dcdcc7c0c4c4dbd8ddd7cdf4d7d0d79ad3dbc2">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:
    Purpose: The Council advises and makes recommendations to the 
Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis. Specifically, the Council makes recommendations regarding 
policies, strategies, objectives, and priorities; addresses the 
development and application of new technologies; and reviews the extent 
to which progress has been made toward eliminating tuberculosis.

[[Page 28013]]

    Matters to be Considered: The agenda will include discussions on 
(1) NIH-funded clinical trials; (2) domestic pediatric tuberculosis; 
(3) immigration and tuberculosis; and (4) considerations for bringing 
new tuberculosis drugs to market. Agenda items are subject to change as 
priorities dictate.

Public Participation

    Written Public Comment: Members of the public are welcome to submit 
written comments in advance of the meeting. Written comments must be 
submitted by emailing <a href="/cdn-cgi/l/email-protection#aec0cdc6c6dddadedec1c2c7cdd7eecdcacd80c9c1d8"><span class="__cf_email__" data-cfemail="016f626969727571716e6d686278416265622f666e77">[email protected]</span></a> with subject line ``June 
ACET Public Comment Registration'' by June 7, 2022.
    Oral Public Comment: Individuals who would like to make an oral 
comment during the public comment period must register by emailing 
<a href="/cdn-cgi/l/email-protection#f39d909b9b808783839c9f9a908ab3909790dd949c85"><span class="__cf_email__" data-cfemail="7c121f14140f080c0c1310151f053c1f181f521b130a">[email protected]</span></a> with subject line ``June ACET Public Comment 
Registration'' by June 16, 2022. The public comment period is on June 
22, 2022, at 11:55 a.m., EDT.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-09949 Filed 5-9-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>